Other News

Cardiovascular Systems, Inc. Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has completed a minority investment and entered into an acquisition option agreement with CarePICS, LLC (CarePICS®), a telehealth company offering a virtual care platform designed to improve the outcomes of patients suffering from peripheral artery disease (PAD), […]

Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders

MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis have voluntarily agreed to step down from the […]

RapidAI Named Exclusive Advanced Neuroimaging Partner for the WSO and SIECV Stroke Center Certification Program in Latin America

RapidAI Partners with the World Stroke Organization and Sociedad Iberoamericana de Enfermedad Cerebrovascular to Expand the Availability of AI-Powered Stroke Imaging Throughout Latin America MENLO PARK, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced cerebrovascular imaging, today announced it has partnered with the World Stroke Organization (WSO) and Sociedad Iberoamericana de Enfermedad […]

Oxford Endovascular Ltd raises $10m to develop an origami engineered medical device to prevent brain haemorrhage

Funding will support the company to achieve first in-human data   Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spin-out from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in […]

Medcura publishes successful results from clinical study

Demonstrating rapid hemorrhage control and improved patient outcomes RIVERDALE, Md., April 7, 2021 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, announced today that it has published the results of a peer-reviewed clinical study at the University of Chicago in this month’s Cardiovascular Catheterization and Interventions (CCI)https://www.medcurainc.com/publications/16998937.pdf. This first-in-human study evaluated the clinical use of […]

TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System

Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks ANDOVER, Mass., April 6, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics’ clinical […]

Enrollment Completed in Clinical Trial Evaluating Effect of Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born With Single Ventricle Physiology

DUARTE, Calif., April 7, 2021 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today that enrollment is now complete in a clinical trial evaluating the effect of an exclusive human milk diet (EHMD),1 including a specialty fortifier, for term infants who have undergone a corrective procedure for […]

Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed

Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution MISGAV, Israel, April 7, 2021 /PRNewswire/ —  Vvital Biomed Ltd. (“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings […]

NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) and the Society of Vascular and Interventional Neurology (SVIN) Form New Alliance

FAIRFAX, Va., April 7, 2021 /PRNewswire/ — The Society of NeuroInterventional Surgery (SNIS) and NeuroPoint Alliance (NPA) are pleased to welcome the Society of Vascular and Interventional Neurology (SVIN) to the NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD).  SVIN joins SNIS and NPA to expand the breadth and depth of the NVQI-QOD, the premier […]